Related Experiment Video
Updated: Aug 22, 2026
Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Prediction of chemotherapeutic response in ovarian cancer with DNA microarray expression profiling
Zachariah E Selvanayagam1, Tak Hong Cheung, Nien Wei
1Department of Pediatrics, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, USA.
Abstract:
Ovarian carcinoma is a leading cause of gynecologic cancer death in women. Despite treatment, a large number of women with ovarian cancer eventually relapse and die of the disease. Hence, recurrent ovarian cancer continues to be a therapeutic dilemma, possibly a result of the emergence of drug resistance during relapse. Recent advances in expression genomics enable global transcript analysis that leads to molecular classification of cancers and prediction of outcome and treatment response. We did a cDNA microarray examination of the expression profiles of eight primary ovarian cancers stratified into two groups based on their chemotherapeutic response. We applied a voice-speech-pattern recognition algorithm for microarray data analysis and were able to model and predict the response of these patients to chemotherapy from their expression profiles. Hence, gene expression profiling by means of DNA microarray may be applied diagnostically for predicting treatment response in ovarian cancer.
Insights
Gene expression profiling using DNA microarrays can predict chemotherapy response in ovarian cancer patients. This approach may help overcome therapeutic dilemmas associated with recurrent ovarian cancer and drug resistance.
Area of Science:
- Oncology
- Genomics
- Bioinformatics
Background:
- Ovarian carcinoma is a major cause of gynecologic cancer mortality.
- Recurrent ovarian cancer presents a therapeutic challenge, often linked to drug resistance.
- Expression genomics offers tools for molecular cancer classification and outcome prediction.
Purpose of the Study:
- To investigate the potential of gene expression profiling for predicting chemotherapy response in ovarian cancer.
- To explore the application of microarray data analysis in identifying predictive molecular signatures.
Main Methods:
- Conducted a cDNA microarray examination of primary ovarian cancer tissues.
- Stratified eight ovarian cancer samples based on chemotherapeutic response.
- Utilized a voice-speech-pattern recognition algorithm for analyzing microarray data.
Main Results:
- Successfully modeled and predicted patient response to chemotherapy based on expression profiles.
- Demonstrated a correlation between gene expression patterns and treatment outcomes.
Conclusions:
- Gene expression profiling via DNA microarray is a promising diagnostic tool for predicting treatment response in ovarian cancer.
- This method may aid in managing recurrent ovarian cancer and overcoming drug resistance.
